Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.0029
Abstract: This analysis of 2 randomized clinical trials evaluates long-term (52 weeks) efficacy and safety of upadacitinib treatment in patients with atopic dermatitis. read more here.
Keywords: safety upadacitinib; upadacitinib patients; efficacy safety; atopic dermatitis ... See more keywords